SIH Partners’s Precigen PGEN Stock Holding History

SIH Partners’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-19,203	Closed	-$28.6K	–	272
2025 Q1	$28.6K	Buy	+19,203	New	+$30.2K	﹤0.01%	259

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

SIH Partners's PGEN Position: Q2 2025 in Review

SIH Partners sold out of Precigen (PGEN) in Q2 2025, closing a stake of 19,203 shares — an estimated $28.6K sold.

SIH Partners first reported a position in PGEN in Q1 2025 and held it in 1 quarter. The position peaked at $28.6K in Q1 2025. 147 funds tracked by Wall St. Rank hold PGEN as of Q2 2025.

SIH Partners reported no remaining Precigen position as of Q2 2025 after selling out during the quarter.
SIH Partners sold 19,203 Precigen shares in Q2 2025, an estimated $28.6K.
SIH Partners first reported a position in Precigen in Q1 2025 and held it in 1 quarter.
SIH Partners's Precigen position peaked at $28.6K in Q1 2025.
147 funds tracked by Wall St. Rank held Precigen as of Q2 2025.

Based on SIH Partners's 13F filing for Q2 2025, filed 14 Aug 2025.